Kobayashi Pharmaceutical Ratios and Metrics

Market cap in millions JPY. Fiscal year is January - December.

Millions JPY. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Feb '26 Feb 12, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	408,269	403,511	463,131	503,841	650,295	704,427
Market Cap Growth	-4.70%	-12.87%	-8.08%	-22.52%	-7.69%	-28.53%
Enterprise Value	338,342	346,251	412,429	409,238	545,580	602,944
Last Close Price	5492.00	5428.00	6110.34	6545.86	8584.51	8506.77
PE Ratio	111.67	110.37	46.01	24.77	32.48	35.73
Forward PE	28.90	30.37	30.11	24.52	33.46	34.40
PS Ratio	2.46	2.44	2.80	2.91	3.91	4.54
PB Ratio	1.93	1.91	2.17	2.46	3.29	3.60
P/TBV Ratio	2.11	2.08	2.40	2.75	3.52	3.85
P/FCF Ratio	-	-	-	89.91	37.88	37.56
P/OCF Ratio	-	-	41.18	27.44	20.38	31.42
PEG Ratio	2.31	2.43	-	20.43	13.39	11.08
EV/Sales Ratio	2.04	2.09	2.49	2.36	3.28	3.88
EV/EBITDA Ratio	14.75	15.09	12.60	12.92	17.12	19.59
EV/EBIT Ratio	22.67	23.20	16.69	15.97	20.58	23.23
EV/FCF Ratio	-	-	-	73.03	31.78	32.15
Debt / Equity Ratio	0.00	0.00	0.00	0.01	0.00	0.00
Debt / EBITDA Ratio	0.03	0.03	0.03	0.03	0.02	0.02
Debt / FCF Ratio	-	-	-	0.18	0.05	0.03
Net Debt / Equity Ratio	-0.33	-0.33	-0.30	-0.38	-0.52	-0.55
Net Debt / EBITDA Ratio	-3.05	-3.05	-1.98	-2.49	-3.26	-3.52
Net Debt / FCF Ratio	-	-	4.38	-14.07	-6.04	-5.78
Asset Turnover	0.61	0.61	0.62	0.66	0.65	0.63
Inventory Turnover	3.45	3.45	3.37	3.88	4.51	4.55
Quick Ratio	2.04	2.04	2.48	2.37	2.94	3.24
Current Ratio	2.48	2.48	3.11	2.82	3.34	3.59
Return on Equity (ROE)	1.72%	1.72%	4.81%	10.10%	10.18%	10.43%
Return on Assets (ROA)	3.45%	3.45%	5.80%	6.12%	6.52%	6.61%
Return on Invested Capital (ROIC)	9.87%	10.08%	13.03%	17.18%	20.94%	21.02%
Return on Capital Employed (ROCE)	6.90%	6.90%	11.30%	12.10%	13.00%	12.90%
Earnings Yield	0.90%	0.91%	2.17%	4.04%	3.08%	2.80%
FCF Yield	-	-	-3.20%	1.11%	2.64%	2.66%
Dividend Yield	1.96%	-	1.67%	1.54%	1.05%	0.98%
Payout Ratio	-	-	74.55%	35.52%	32.51%	31.71%
Buyback Yield / Dilution	-0.00%	-0.00%	1.98%	1.67%	1.27%	0.05%
Total Shareholder Return	1.96%	-0.00%	3.65%	3.21%	2.32%	1.03%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.